SLC25A45 as a prognostic biomarker promotes malignant progression via mutant p53 in hepatocellular carcinoma.

Li K, Shen Y, Wei P, Geng X, Huang L, Peng C, Mei Y

Open source

DOI
10.21037/jgo-2026-0725
Published
2026 Aug 31
Container
Journal of gastrointestinal oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/jgo-2026-0725,
  title = {SLC25A45 as a prognostic biomarker promotes malignant progression via mutant p53 in hepatocellular carcinoma.},
  author = {Li K and Shen Y and Wei P and Geng X and Huang L and Peng C and Mei Y},
  year = {2026},
  journal = {Journal of gastrointestinal oncology},
  doi = {10.21037/jgo-2026-0725},
  url = {https://doi.org/10.21037/jgo-2026-0725}
}

RIS

TY  - JOUR
TI  - SLC25A45 as a prognostic biomarker promotes malignant progression via mutant p53 in hepatocellular carcinoma.
AU  - Li K
AU  - Shen Y
AU  - Wei P
AU  - Geng X
AU  - Huang L
AU  - Peng C
AU  - Mei Y
PY  - 2026
JO  - Journal of gastrointestinal oncology
DO  - 10.21037/jgo-2026-0725
UR  - https://doi.org/10.21037/jgo-2026-0725
ER  - 

APA

K, L., Y, S., P, W., X, G., L, H., C, P., & Y, M. (2026). SLC25A45 as a prognostic biomarker promotes malignant progression via mutant p53 in hepatocellular carcinoma.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-2026-0725

Source records